SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Reents Scott T – ‘3’ for 6/28/22 re: AbbVie Inc.

On:  Friday, 7/8/22, at 1:11pm ET   ·   For:  6/28/22   ·   As:  Officer   ·   Accession #:  1415889-22-7553   ·   File #:  1-35565

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/08/22  Reents Scott T                    3          Officer     2:14K  AbbVie Inc.                       SEC Connect

Initial Statement of Beneficial Ownership of Securities by an Insider   —   Form 3   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 3           Initial Statement of Beneficial Ownership of        HTML     11K 
                Securities by an Insider --                                      
                form3-07082022_100701.xml/2.6                                    
 2: EX-24       Power of Attorney                                   HTML      7K

‘3’   —   Initial Statement of Beneficial Ownership of Securities by an Insider — form3-07082022_100701.xml/2.6



        

This ‘3’ Document is an XML Data File that may be rendered in various formats:

  Form 3    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
Plain Text rendering:  Initial Statement of Beneficial Ownership of Securities by an Insider — form3-07082022_100701.xml/2.6
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0206
Document Type:  3
Period of Report:  6/28/22
No Securities Owned:  0
Issuer:
Issuer CIK:  1551152
Issuer Name:  AbbVie Inc.
Issuer Trading Symbol:  ABBV
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1937048
Owner Name:  Reents Scott T
Reporting Owner Address:
Owner Street 1:  1 NORTH WAUKEGA
Owner Street 2:
Owner City:  NORTH CHICAGO
Owner State:  IL
Owner ZIP Code:  60064
Owner State Description:
Reporting Owner Relationship:
Is Director?  No
Is Officer?  Yes
Is Ten Percent Owner?  No
Is Other?  No
Officer Title:  SVP, Chief Financial Officer
Other Text:
Non-Derivative Table:
Non-Derivative Holding:
Security Title:
Value:  Common Stock, $0.01 par value
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  809
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Nature of Ownership:
Value:
Derivative Table:
Derivative Holding:
Security Title:
Value:  Option (Right to buy)
Conversion or Exercise Price:
Value:  61.36
Exercise Date:
Value:  2/16/18
Footnote ID:  F1
Expiration Date:
Value:  2/15/28
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  14,140
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Nature of Ownership:
Value:
Derivative Holding:
Security Title:
Value:  Option (Right to buy)
Conversion or Exercise Price:
Value:  114.36
Exercise Date:
Value:  2/15/19
Footnote ID:  F2
Expiration Date:
Value:  2/14/28
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  11,810
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Nature of Ownership:
Value:
Derivative Holding:
Security Title:
Value:  Option (Right to buy)
Conversion or Exercise Price:
Value:  79.02
Exercise Date:
Value:  2/21/20
Footnote ID:  F3
Expiration Date:
Value:  2/20/29
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  19,470
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Nature of Ownership:
Value:
Derivative Holding:
Security Title:
Value:  Option (Right to buy)
Conversion or Exercise Price:
Value:  93.50
Exercise Date:
Value:  2/20/21
Footnote ID:  F4
Expiration Date:
Value:  2/19/30
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  28,641
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Nature of Ownership:
Value:
Derivative Holding:
Security Title:
Value:  Option (Right to buy)
Conversion or Exercise Price:
Value:  105.92
Exercise Date:
Value:  2/18/22
Footnote ID:  F5
Expiration Date:
Value:  2/17/31
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  15,527
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Nature of Ownership:
Value:
Derivative Holding:
Security Title:
Value:  Option (Right to buy)
Conversion or Exercise Price:
Value:  144.54
Exercise Date:
Value:  2/17/23
Footnote ID:  F6
Expiration Date:
Value:  2/16/32
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  11,383
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Nature of Ownership:
Value:
Footnotes:
Footnote - F1:  Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 4,714 shares on 2/16/18, as to 4,713 shares on 2/16/19 and as to 4,713 shares on 2/16/20.
Footnote - F2:  Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 3,936 shares on 2/15/19, as to 3,937 shares on 2/15/20 and as to 3,937 shares on 2/15/21.
Footnote - F3:  Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 6,490 shares on 2/21/20, as to 6,490 shares on 2/21/21 and as to 6,490 shares on 2/21/22.
Footnote - F4:  Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 9,547 shares on 2/20/21, as to 9,547 shares on 2/20/22 and will become exercisable as to 9,547 shares on 2/20/23.
Footnote - F5:  Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 5,176 shares on 2/18/22, and will become exercisable as to 5,176 shares on 2/18/23 and as to 5,175 shares on 2/18/24.
Footnote - F6:  Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option will become exercisable as to 3,794 shares on 2/17/23, as to 3,794 shares on 2/17/24 and as to 3,795 shares on 2/17/25.
Owner Signature:
Signature Name:  Steven L. Scrogham, attorney-in-fact for Scott T. Reents
Signature Date:  7/8/22


↑Top
Filing Submission 0001415889-22-007553   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., Apr. 27, 11:52:22.1pm ET